Redox Ltd
F:AE0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Redox Ltd
F:AE0
|
AU |
|
Bright Minds Biosciences Inc
NASDAQ:DRUG
|
US |
|
Silver X Mining Corp
OTC:AGXPF
|
CA |
|
D
|
Deutsche Grundstuecksauktionen vormals Berliner Grundstuecksauktionen AG
DUS:DGR
|
DE |
|
Lithos Energy Ltd
OTC:LITSF
|
CA |
|
New Peoples Bankshares Inc
OTC:NWPP
|
US |
Earnings Calls
Last Earnings Call
Revenue Growth: Redox reported first half 2026 sales of $674 million, up 6.6%, with strength in Industrial and Food segments and North America driving results.
Margins: Gross profit margin held steady at 21.5%, showing resilience despite subdued global demand.
EPS & Returns: Earnings per share rose 8.9% to $0.083, while return on invested capital improved to 14%.
Cash Position: The company finished the half with a strong net cash position of $145 million and no net debt, providing flexibility for future growth.
Dividend: The board declared an interim dividend of $0.065 per share, representing a 78% payout of net profit, within the targeted range.
Outlook & M&A: Management sees ongoing growth opportunities in North America and a strong M&A pipeline, but remains disciplined and does not expect an imminent acquisition.
Pricing Environment: Product prices remained stable in the first half, but management expects upward pricing pressure in the future.